HFpEF (n = 50) | HTN (n = 56) | Age-matched control (n = 46) | P value | |
---|---|---|---|---|
Mean ± SD or n (%) | ||||
Age (years) | 67.4 ± 8.75 | 59.8 ± 9.43 | 58.2 ± 6.34 | < 0.001* |
Male sex | 19 (38.0) | 29 (51.8) | 22 (47.8) | 0.349 |
Body Mass Index (kg/m2) | 31.5 ± 6.79 | 26.9 ± 3.67 | 24.8 ± 3.38 | < 0.001* |
Systolic BP (mmHg) | 120.8 ± 25.0 | 136.6 ± 16.5 | 129.2 ± 15.1 | 0.003* |
Diastolic BP (mmHg) | 65.5 ± 20.1 | 83.7 ± 10.7 | 82.4 ± 10.6 | < 0.001* |
Heart rate (beat/min) | 67.4 ± 13.0 | 69.3 ± 10.2 | 69.4 ± 10.7 | 0.626 |
Atrial fibrillation | 42 (84.0) | 5 (8.9) | 1 (2.1) | < 0.001 * |
Risk factors | ||||
Hypertension | 35 (70.0) | 56 (100.0) | 1 (2.2) | < 0.001* |
Smoking | 0.153 | |||
Ex-smoker | 11 (22.0) | 9 (16.1) | 7 (15.2) | |
Current smoker | 6 (12.0) | 12 (21.4) | 7 (15.2) | |
Hyperlipidemia | 31 (62.0) | 19 (33.9) | 3 (6.5) | < 0.001* |
Diabetes mellitus | 16 (32.0) | 1 (1.8) | 0 (0.0) | < 0.001* |
Prior myocardial infarction | 4 (8.0) | 0 (0.0) | 0 (0.0) | < 0.001* |
NT-proBNP (pg/dl) | 677.6 ± 1077.5 | 87.7 ± 70.4 | 88.8 ± 102.9 | 0.021* |
NYHA classification | < 0.001* | |||
I | 1 (100) | 0 (0.0) | 0 (0.0) | |
II | 18 (100) | 0 (0.0) | 0 (0.0) | |
III | 19 (100) | 0 (0.0) | 0 (0.0) | |
Medications | ||||
ACEi or ARB | 22 (44.0) | 8 (14.3) | 0 (0.0) | < 0.001* |
Beta-blocker | 27 (54.0) | 17 (30.4) | 2 (4.3) | < 0.001* |
Diuretics | 28 (56.0) | 20 (35.7) | 0 (0.0) | < 0.001* |
Calcium channel blocker | 14 (28.0) | 16 (28.6) | 0 (0.0) | < 0.001* |
Aspirin | 30 (60.0) | 15 (26.8) | 1 (2.2) | < 0.001* |
Statin | 24 (48.0) | 15 (26.8) | 1 (2.2) | < 0.001* |